Lowering Off‑Target Uptake in Biologic Radiopharmaceuticals through Protein Engineering
- Utilizing intracellular trapping to prevent isotope and daughter escape, strengthening tumor retention
- Providing a mechanistic basis for safer and more effective application of alpha emitters
- Leveraging tumor-specific metabolic activity to achieve sufficient radioconjugate accumulation